Key result
MCT-enriched formula promotes metabolic improvement and brown adipose tissue regression in neonatal CGL1.
Why the study?
Neonatal diagnosis of congenital generalized lipodystrophies remains uncommon because the typical phenotype of generalized lipoatrophy and severe metabolic complications may not yet be fully established.
Case Report (n=1)
Prominent immature brown adipose tissue accompanied by severe neonatal hypertriglyceridemia may serve as an early clinical sign of congenital generalized lipodystrophy type 1, warranting prompt genetic evaluation and nutritional management with medium-chain triglyceride-enriched formula.
Congenital generalized lipodystrophies (CGL) are genetic disorders characterized by generalized lipoatrophy and severe metabolic complications. Neonatal diagnosis remains uncommon because the typical phenotype may not yet be fully established. We report a preterm female neonate presenting with rapidly progressive bilateral cervical, axillary, and inguinal masses. Imaging and histopathological examination identified prominent immature brown adipose tissue. Severe hypertriglyceridemia prompted suspicion of CGL, which was subsequently confirmed by identification of a homozygous pathogenic AGPAT2 variant. During follow-up, generalized lipoatrophy, insulin resistance, and hepatic steatosis progressively developed, whereas the brown adipose tissue deposits completely regressed by 8 months of age. Nutritional management with a medium-chain triglyceride-enriched formula resulted in marked metabolic improvement. This case highlights that prominent immature brown adipose tissue associated with severe neonatal hypertriglyceridemia may represent an early manifestation of CGL1 and should prompt early genetic investigation.
No takes yet. Share an insight, caveat, or question.
Marie et al. (2026) conducted a case report in Congenital generalized lipodystrophy type 1 (CGL1) (n=1). Medium-chain triglyceride-enriched formula was evaluated on Metabolic improvement and regression of brown adipose tissue deposits. Nutritional management with a medium-chain triglyceride-enriched formula in 1 preterm neonate with CGL1 yielded marked metabolic improvement, with brown adipose tissue regression by 8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: